SE444647B - Forfarande for framstellning av ett fast, stabilt endotoxin- och pyrogenfritt tymosin 5-preparat - Google Patents

Forfarande for framstellning av ett fast, stabilt endotoxin- och pyrogenfritt tymosin 5-preparat

Info

Publication number
SE444647B
SE444647B SE7802014A SE7802014A SE444647B SE 444647 B SE444647 B SE 444647B SE 7802014 A SE7802014 A SE 7802014A SE 7802014 A SE7802014 A SE 7802014A SE 444647 B SE444647 B SE 444647B
Authority
SE
Sweden
Prior art keywords
preparation
thymosin fraction
solid
thymosin
permeate
Prior art date
Application number
SE7802014A
Other languages
English (en)
Swedish (sv)
Other versions
SE7802014L (sv
Inventor
W C Mcgregor
H L Newmark
A H Ramel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7802014L publication Critical patent/SE7802014L/xx
Publication of SE444647B publication Critical patent/SE444647B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SE7802014A 1977-02-22 1978-02-21 Forfarande for framstellning av ett fast, stabilt endotoxin- och pyrogenfritt tymosin 5-preparat SE444647B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (2)

Publication Number Publication Date
SE7802014L SE7802014L (sv) 1978-08-23
SE444647B true SE444647B (sv) 1986-04-28

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7802014A SE444647B (sv) 1977-02-22 1978-02-21 Forfarande for framstellning av ett fast, stabilt endotoxin- och pyrogenfritt tymosin 5-preparat

Country Status (20)

Country Link
US (1) US4082737A (de)
JP (1) JPS53104719A (de)
AT (1) AT363177B (de)
AU (1) AU516946B2 (de)
BE (1) BE864139A (de)
CA (1) CA1099633A (de)
CH (1) CH632164A5 (de)
DE (1) DE2807202A1 (de)
DK (1) DK78378A (de)
FR (1) FR2380782A1 (de)
GB (1) GB1546027A (de)
IE (1) IE46409B1 (de)
IL (1) IL54063A0 (de)
IT (1) IT1092337B (de)
LU (1) LU79090A1 (de)
NL (1) NL189281C (de)
NZ (1) NZ186489A (de)
PH (1) PH13858A (de)
SE (1) SE444647B (de)
ZA (1) ZA78890B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
WO1982000407A1 (en) * 1980-08-08 1982-02-18 Sykes A Improved racking
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
NL189281B (nl) 1992-10-01
PH13858A (en) 1980-10-22
AU516946B2 (en) 1981-07-02
IE46409B1 (en) 1983-06-01
FR2380782B1 (de) 1980-01-18
IL54063A0 (en) 1978-04-30
DK78378A (da) 1978-08-23
LU79090A1 (fr) 1979-05-25
NL189281C (nl) 1993-03-01
CH632164A5 (de) 1982-09-30
AU3334378A (en) 1979-08-23
DE2807202C2 (de) 1987-04-02
ATA124578A (de) 1980-12-15
JPS53104719A (en) 1978-09-12
FR2380782A1 (fr) 1978-09-15
AT363177B (de) 1981-07-10
NL7801422A (nl) 1978-08-24
SE7802014L (sv) 1978-08-23
DE2807202A1 (de) 1978-08-24
ZA78890B (en) 1979-01-31
JPS618806B2 (de) 1986-03-18
BE864139A (fr) 1978-08-21
IE780335L (en) 1978-08-22
NZ186489A (en) 1981-01-23
US4082737A (en) 1978-04-04
CA1099633A (en) 1981-04-21
IT7819791A0 (it) 1978-01-30
IT1092337B (it) 1985-07-06
GB1546027A (en) 1979-05-16

Similar Documents

Publication Publication Date Title
SE444647B (sv) Forfarande for framstellning av ett fast, stabilt endotoxin- och pyrogenfritt tymosin 5-preparat
Abel et al. On the removal of diffusible substances from the circulating blood by means of dialysis
RU2085191C1 (ru) Жидкая антибактериальная композиция
DE3026398C2 (de)
Lee et al. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity
PE20000265A1 (es) Composiciones que contienen virus y metodos para concentrar preparados de virus
KR960704619A (ko) 투석기 재생 방법(methods for reprocessing dialyzers)
JPH0365326B2 (de)
PT2399606E (pt) Um método para a preparação de uma composição farmacêutica contendo um transportador de oxigénio estável ao calor
KR101343369B1 (ko) 복막 투석 유체
Enna et al. Phenol red absorption from the rat lung: evidence of carrier transport
JPS5967228A (ja) 寒冷不溶性グロブリンの凍結乾燥方法
Stankowski et al. A combined study of aggregation, membrane affinity and pore activity of natural and modified melittin
Burrell et al. Mediators of Pulmonary Injury Induced by Inhalation of Bacterial Endotoxin1-3
DE3046565A1 (de) Verfahren zur trennung von blutserumproteinen
Blanot et al. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation
Iseki et al. The pH dependent uptake of enoxacin by rat intestinal brush‐border membrane vesicles
US4289783A (en) Etomidate-containing compositions
BR112021006643A2 (pt) composições e métodos para aumentar capacidade de distribuição sistêmica, tolerância e eficácia de peptídeos macrocíclicos catiônicos
Coward Effects of actinomycin D on regeneration give evidence of sequential gene activation
JPH08299433A (ja) 血液処理器の製造方法及び血液処理器
Williams et al. Renal handling of aromatic amino acids, sugar, and standard glomerular markers in winter flounder
Pegg et al. Renal preservation by hypothermic perfusion. III. The lack of influence of pulsatile flow
Dalgliesh Permeation of bovine erythrocytes with glycerol and their protection during rapid freezing and thawing
Joshi et al. Cellulose triacetate membranes for seawater desalination

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7802014-6

Format of ref document f/p: F